Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000897069-23-000278)

Filing Details

Accession Number:: 0000897069-23-000278
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-04-14 18:16:56
Reporting Period:: 2023-04-14

Accepted Time:: 2023-04-14 18:16:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533743	Processa Pharmaceuticals Inc.	PCSA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378166	David Young	C/O Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover MD 21076	President & Ceo	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-04-14	20,000	$0.55	430,424	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	619,677	Indirect	By Young-Plaisance Revocable Trust
Common Stock	215,703	Indirect	By Family Entities
Common Stock	370,887	Indirect	By CorLyst, LLC